BLS — BLS Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- AU$255.28m
- AU$250.42m
- AU$74.23m
Brief: Bioxyne Announces Dual Listing On Frankfurt Stock Exchange
Brief: Bioxyne Ltd's Unit Well Positioned To Capitalise On Easing Regulations On U.S. Cannabis Classification
Brief: Bioxyne Ltd Received Import Authorisations Medical Cannabis Products
Brief: Bioxyne Reports Full Year FY2026 Revenue Guidance Of A$65 Million - A$75 Million
Brief: Bioxyne Filed Summons Against Major Shareholder
Australia's Bioxyne jumps on strong quarterly results, upbeat outlook
Brief: Bioxyne Says FY25 Unaudited Revenue Of A$29.3 Million
Australia's Bioxyne jumps on entering German market with $3.7 mln deal
Brief: Bioxyne Enters German Market With Agreement
Brief: Bioxyne Ltd Says Receipt Of Certificate Of GMP Compliance With Europe, Others
Brief: Bioxyne Says FY25 Revenue Guidance Upgraded To A$28M
Australia's Bioxyne surges after raising fiscal year revenue outlook
Brief: Bioxyne Posts A$7.2 Mln Q3 Revenue
Brief: Bioxyne Signs Exclusive A$7M Manufacturing And Supply Agreement With NectarTek Australia
Brief: Bioxyne To Raise A$3 Mln At A$0.025 Per Share
Brief: Bioxyne Seeks Trading Halt
Brief: Bioxyne Posts A$8.1 Mln Q2 Revenue
Brief: Bioxyne Posts Quarterly Revenue Of A$4.6 Million
Brief: Bioxyne Posts Revenue Of A$3.1 Million For Quarter